Status:
COMPLETED
Prize Contingency Management for Cocaine-Dependent Methadone Patients
Lead Sponsor:
UConn Health
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Cocaine Abuse
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators will randomize 300 cocaine-dependent methadone patients to 1 of 6 conditions: (a) a control group, (b) a contingency management condition that arranges a 100% probability of winning ...
Eligibility Criteria
Inclusion
- age \> 18 years
- current DSM-IV diagnosis of cocaine dependence
- enrolled at the clinic for \>3 months
- on a stable dose of methadone (no changes) for \>1 month and not requesting a dose alteration
- submitted \>1 clinic cocaine positive sample in the last 6 months
- English speaking
- pass a quiz related to understanding the informed consent form
Exclusion
- serious, uncontrolled psychiatric illness
- significant cognitive impairment
- in recovery from pathological gambling
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2018
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT01401270
Start Date
November 1 2011
End Date
May 1 2018
Last Update
March 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Connecticut Health Center
Farmington, Connecticut, United States, 06030